Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CASTLE BIOSCIENCES INC | Director | Common Stock | 13.3K | $416K | $31.32 | Dec 3, 2024 | The Bradbury Family Trust |
CASTLE BIOSCIENCES INC | Director | Common Stock | 10K | $314K | $31.32 | Dec 3, 2024 | By LLC |
CASTLE BIOSCIENCES INC | Director | Common Stock | 2.85K | $89.3K | $31.32 | Dec 3, 2024 | By Annette Bradbury Irrecovable Descendant's Trust |
CASTLE BIOSCIENCES INC | Director | Common Stock | 2.85K | $89.3K | $31.32 | Dec 3, 2024 | By Daniel Bradbury Irrecovable Descendant's Trust |
Vivani Medical, Inc. | Director | Non-Qualified Stock Option (right to buy) | 26.1K | $37.4K | $1.43 | Mar 27, 2024 | Direct |
CASTLE BIOSCIENCES INC | Director | Restricted Stock Units | 0 | $0 | $24.95 | May 25, 2024 | Direct |
Vivani Medical, Inc. | Director | Common Stock | 0 | $0 | $1.01 | Mar 4, 2024 | Direct |
Equillium, Inc. | Executive Chairman, Director, 10%+ Owner | Employee Stock Option (right to buy) | 50K | Jan 2, 2024 | Direct | ||
Vivani Medical, Inc. | Director | Common Stock Option | 34.8K | Jun 27, 2024 | Direct | ||
INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | Nov 8, 2023 | Direct | |
INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | Nov 8, 2023 | Indirect | |
INTERCEPT PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | Nov 8, 2023 | Direct |